Neurocrine Biosciences
NBIX
#1290
Rank
A$21.92 B
Marketcap
$216.59
Share price
0.34%
Change (1 day)
21.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company